Table 2. Relationship between RASA1 and clinical-pathological features of TNBC.
| Variables | Cases(n=136) | RASA1 | P value | |
| Low (n=50) | High(n=86) | |||
| Age (years) | ||||
| <40 | 35 | 13(37.1%) | 22(62.9%) | 0.230 |
| 40-60 | 87 | 29(33.3%) | 58(66.7%) | |
| >60 | 14 | 8(57.1%) | 6(42.9%) | |
| Menopause status | ||||
| No | 82 | 28(34.1%) | 54(65.9%) | 0.274 |
| Yes | 54 | 22(40.7%) | 32(59.3%) | |
| T stage | ||||
| T1-T2 | 122 | 39(32.0%) | 83(68.0%) | 0.001* |
| T3-T4 | 14 | 11(78.6%) | 3(21.4%) | |
| N stage | ||||
| N0 | 75 | 15(20.0%) | 60(80.0%) | <0.001* |
| N1-3 | 61 | 35(57.4%) | 26(42.6%) | |
| TNM stage | ||||
| I-II | 107 | 29(27.1%) | 78(72.9%) | <0.001* |
| III-IV | 29 | 21(72.4%) | 8(27.6%) | |
*P < 0.05, statistically significant